Related Experiment Videos

Three cases of severe mania successfully treated with high-dosage lithium-carbonate

K Thau1, K Meszaros, C Simhandl

  • 1Department of Psychiatry, University of Vienna, Austria.

Pharmacopsychiatry
|May 1, 1991
PubMed

Insights

High-dose lithium carbonate effectively treated severe mania in three female patients unresponsive to neuroleptics. Achieving therapeutic lithium blood levels (1.3-1.51 mmol/l) resulted in significant symptom improvement without observed toxicity.

Area of Science:

  • Psychiatry
  • Pharmacology
  • Neuroscience

Background:

  • Severe mania often requires intensive treatment.
  • Neuroleptic medications can be ineffective in some severe mania cases.
  • Exploring alternative or adjunctive treatments is crucial for treatment-resistant mania.

Observation:

  • Three female patients with severe mania were unresponsive to high-dose neuroleptics.
  • A high-dose lithium carbonate regimen was initiated.
  • Rapid dose escalation achieved target lithium blood levels (1.3-1.51 mmol/l).

Findings:

  • Patients demonstrated significant improvement (75-82% on Bech-Rafaelsen Scale) at high lithium levels.
  • Concomitant medications were successfully reduced.
  • No toxic effects of lithium carbonate were observed during the treatment period.

Implications:

  • High-dose lithium carbonate may be a viable option for treatment-resistant severe mania.
  • This approach could potentially shorten hospitalization duration.
  • Careful monitoring is essential when using high-dose lithium therapy.

Related Concept Videos